NASDAQ:GHSI Guardion Health Sciences (GHSI) Stock Price, News & Analysis → $1,500 to $9,400 in one month? (A.I. Trade List) (From Prosper Trading Academy) (Ad) Free GHSI Stock Alerts $9.25 +0.14 (+1.54%) (As of 05/24/2024 ET) Add Compare Share Share Today's Range$9.17▼$9.2950-Day Range$7.82▼$9.2752-Week Range$5.01▼$10.75Volume3,182 shsAverage Volume8,537 shsMarket Capitalization$11.84 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get Guardion Health Sciences alerts: Email Address Ad Colonial MetalsThis could mean the end of the U.S dollar…Experts say global conflict and escalated tensions could send the U.S. economy spiraling… Which is why elites and billionaire investors turn to physical precious metals in times like these.Download your FREE Precious Metals Guide Now. About Guardion Health Sciences Stock (NASDAQ:GHSI)Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.Read More GHSI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GHSI Stock News HeadlinesMay 24 at 8:20 AM | finanznachrichten.deGuardion Health Sciences, Inc.: Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv BusinessMay 23 at 3:00 PM | globenewswire.comGuardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv BusinessMay 21, 2024 | finance.yahoo.comGuardion Health Sciences Announces its Largest Stockholder Has Voted in Favor of Proposals to Sell the Viactiv Business and the Liquidation Plan at the Company’s Special Meeting of Stockholders to be held on May 23, 2024May 13, 2024 | investorplace.comGHSI Stock Earnings: Guardion Health Sciences Misses EPS, Misses Revenue for Q1 2024May 13, 2024 | globenewswire.comGuardion Health Sciences AnnouncesApril 27, 2024 | msn.comThe Hunger Project Ghana, GHS commemorate World Malaria DayApril 17, 2024 | morningstar.comGuardion Health Sciences Inc GHSIApril 15, 2024 | finance.yahoo.comGuardion Health Sciences, Inc. (GHSI)April 9, 2024 | msn.comMolecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals among healthcare moversApril 4, 2024 | msn.comAccess Bank Ghana makes historic GHS One billion plus profit before taxApril 1, 2024 | finance.yahoo.comWhy Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth WatchingMarch 29, 2024 | markets.businessinsider.comGuardion Health Swings To Annual Net Profit, Revenue ImprovesMarch 29, 2024 | globenewswire.comGuardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023March 28, 2024 | finance.yahoo.comGHS Label Market Set to Achieve Steady Growth with a 3.4% CAGR through 2034 | Future Market Insights Inc.February 24, 2024 | msn.comGuardion Health Sciences (GHSI) Price Target Increased by 233.33% to 40.80February 1, 2024 | realmoney.thestreet.comMaxim gets more bearish on Guardion Health Sciences, downgrades sharesFebruary 1, 2024 | msn.comWhy Guardion Health Sciences Stock Is Up TodayFebruary 1, 2024 | msn.comGuardion Health Sciences Sells Activ to Doctor’s BestJanuary 31, 2024 | marketwatch.comGuardion Health Shares Soar Premarket on Deal to Sell ViactivJanuary 31, 2024 | markets.businessinsider.comWhy Is Guardion Health (GHSI) Stock Up 66% Today?January 30, 2024 | finance.yahoo.comGuardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.November 22, 2023 | msn.comKadjebi GHS exceeds SMC registration, dosing targetNovember 13, 2023 | finance.yahoo.comGuardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023November 6, 2023 | msn.comGHS to launch “ART at 20 celebrations” to showcase impact on livesAugust 25, 2023 | markets.businessinsider.comMaxim Group Sticks to Their Buy Rating for Guardion Health Sciences (GHSI)See More Headlines Receive GHSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today5/25/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:GHSI CUSIPN/A CIK1642375 Webwww.guardionhealth.com Phone(800) 873-5141Fax858-630-5543Employees9Year Founded2009Profitability EPS (Most Recent Fiscal Year)($4.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$160,000.00 Net Margins-16.69% Pretax Margin-16.69% Return on Equity-77.29% Return on Assets-42.08% Debt Debt-to-Equity RatioN/A Current Ratio8.17 Quick Ratio6.49 Sales & Book Value Annual Sales$12.25 million Price / Sales0.97 Cash Flow$0.14 per share Price / Cash Flow65.44 Book Value$2.66 per share Price / Book3.48Miscellaneous Outstanding Shares1,280,000Free Float1,267,000Market Cap$11.84 million OptionableNot Optionable Beta0.90 Social Links The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Robert Neal Weingarten (Age 72)Independent Chairman & Secretary Comp: $110kMs. Janet Hall (Age 65)President & CEO Comp: $704.85kMs. Katie Cox (Age 54)Chief Accounting Officer Comp: $275kMr. Craig J. Sheehan (Age 53)Chief Commercial Officer Comp: $457.5kKey CompetitorsImunonNASDAQ:CLSNOcuphire PharmaNASDAQ:OCUPNabriva TherapeuticsNASDAQ:NBRVKronos BioNASDAQ:KRONAadi BioscienceNASDAQ:AADIView All Competitors GHSI Stock Analysis - Frequently Asked Questions Should I buy or sell Guardion Health Sciences stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Guardion Health Sciences in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" GHSI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GHSI, but not buy additional shares or sell existing shares. View GHSI analyst ratings or view top-rated stocks. How have GHSI shares performed in 2024? Guardion Health Sciences' stock was trading at $5.34 on January 1st, 2024. Since then, GHSI shares have increased by 73.2% and is now trading at $9.25. View the best growth stocks for 2024 here. When is Guardion Health Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our GHSI earnings forecast. How were Guardion Health Sciences' earnings last quarter? Guardion Health Sciences, Inc. (NASDAQ:GHSI) issued its quarterly earnings data on Thursday, March, 28th. The company reported $0.33 earnings per share for the quarter. The company earned $21.56 million during the quarter. Guardion Health Sciences had a negative trailing twelve-month return on equity of 77.29% and a negative net margin of 16.69%. When did Guardion Health Sciences' stock split? Guardion Health Sciences's stock reverse split before market open on Sunday, January 8th 2023. The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. What other stocks do shareholders of Guardion Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Guardion Health Sciences investors own include iBio (IBIO), Biocept (BIOC), Onconova Therapeutics (ONTX), Heat Biologics (HTBX), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Ocugen (OCGN), Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX) and FuelCell Energy (FCEL). When did Guardion Health Sciences IPO? Guardion Health Sciences (GHSI) raised $6 million in an IPO on Friday, April 5th 2019. The company issued 1,500,000 shares at a price of $4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO. How do I buy shares of Guardion Health Sciences? Shares of GHSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GHSI) was last updated on 5/25/2024 by MarketBeat.com Staff From Our PartnersThis could mean the end of the U.S dollar…Colonial MetalsUrgent Nvidia WarningAltimetryBiden FINISHED On June 13th?Paradigm PressWho are Nvidia’s New Silent Partners?Weiss RatingsJust $9 for a Year of Winning Market InsightsBehind the MarketsThe 1,000X Crypto PlaybookTrue Market InsidersClaim Your Complimentary Bitcoin RewardCrypto Swap Profits41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardion Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
